Charles M. Rice

Q: What Schools Are Affiliated With Charles M. Rice

Charles M. Rice is affiliated with the following schools: Washington University in St. Louis, Ohio State University, Massachusetts Institute of Technology, California Institute of Technology, University of Florida, Rockefeller University, Johns Hopkins University, North Carolina State University, University of California, Davis, University of Technology Sydney

Charles M. Rice's AcademicInfluence.com Rankings

Charles M. Rice

Biology

#381

World Rank

#684

Historical Rank

#226

USA Rank

Virology

#15

World Rank

#15

Historical Rank

USA Rank

biology Degrees

Download Badge

Biology

Charles M. Rice's Degrees

PhD Biochemistry California Institute of Technology

Why Is Charles M. Rice Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Charles Moen Rice is an American virologist and Nobel Prize laureate whose main area of research is the Hepatitis C virus. He is a professor of virology at the Rockefeller University in New York City and an adjunct professor at Cornell University and Washington University School of Medicine. At the time of the award he was a faculty at Rockefeller.

(See a Problem?)

Charles M. Rice's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

Complete Replication of Hepatitis C Virus in Cell Culture (2005) (2366)
Interferon-stimulated genes: a complex web of host defenses. (2014) (2092)
Flaviviridae :T he Viruses and Their Replication (2007) (1942)
Flavivirus genome organization, expression, and replication. (1990) (1906)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 (2020) (1744)
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals (2020) (1577)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 (2020) (1524)
Efficient initiation of HCV RNA replication in cell culture. (2000) (1517)
Suppression of inflammation by a synthetic histone mimic (2010) (1354)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry (2007) (1282)
Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource (2013) (1249)
Identification of microRNAs of the herpesvirus family (2005) (1229)
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication (2002) (1215)
A proposed system for the nomenclature of hepatitis C viral genotypes (1994) (1100)
Interferon-stimulated genes and their antiviral effector functions (2011) (1050)
Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response (2015) (1037)
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells (2009) (976)
Expression and identification of hepatitis C virus polyprotein cleavage products (1993) (943)
A diverse array of gene products are effectors of the type I interferon antiviral response (2011) (930)
Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. (1985) (929)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants (2020) (915)
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles (2003) (877)
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help (2003) (864)
Unravelling hepatitis C virus replication from genome to function (2005) (852)
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity (2013) (758)
Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide (1996) (738)
Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. (1997) (735)
Replication of hepatitis C virus (2007) (710)
Molecular biology of the flaviviruses. (1987) (667)
Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites (1993) (640)
Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In Vivo (2000) (618)
Cellular cofactors affecting hepatitis C virus infection and replication (2007) (579)
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics (2006) (538)
Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. (2000) (536)
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies (2013) (535)
Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA (1996) (505)
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase (2005) (492)
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. (2006) (484)
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection (2021) (471)
Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants (1987) (469)
Hepatitis C Virus p7 and NS2 Proteins Are Essential for Production of Infectious Virus (2007) (468)
Neutralizing antibody response during acute and chronic hepatitis C virus infection. (2004) (462)
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses (1994) (462)
A second hepatitis C virus-encoded proteinase. (1993) (460)
MX2 is an interferon-induced inhibitor of HIV-1 infection (2013) (432)
Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. (2007) (430)
Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency (2012) (426)
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR (2003) (426)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants (2020) (417)
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry (2006) (417)
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection (2004) (407)
Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. (2006) (395)
A genetically humanized mouse model for hepatitis C virus infection (2011) (394)
Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. (1989) (389)
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids (2018) (387)
Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics (2010) (386)
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture (2003) (378)
Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini (1994) (377)
Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs (1993) (371)
The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein* (2004) (370)
Complete nucleotide sequence of the genomic RNA of Sindbis virus. (1984) (366)
Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. (2004) (365)
The ins and outs of hepatitis C virus entry and assembly (2013) (360)
Flying under the radar: the immunobiology of hepatitis C. (2007) (353)
The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. (2015) (353)
trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication (1997) (352)
Formation of native hepatitis C virus glycoprotein complexes (1997) (352)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses (2020) (351)
HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. (1995) (350)
Conserved elements in the 3' untranslated region of flavivirus RNAs and potential cyclization sequences. (1987) (347)
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs (2002) (343)
Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. (1990) (342)
Subcellular Localization, Stability, andtrans-Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines (2000) (340)
The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. (1997) (333)
Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes (1993) (331)
Expression of the Zinc-Finger Antiviral Protein Inhibits Alphavirus Replication (2003) (328)
Polypeptide requirements for assembly of functional Sindbis virus replication complexes: a model for the temporal regulation of minus‐ and plus‐strand RNA synthesis. (1994) (325)
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus (2012) (318)
Interferons and viruses: an evolutionary arms race of molecular interactions. (2015) (307)
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response1 (2009) (303)
Enhanced SARS-CoV-2 neutralization by dimeric IgA (2020) (301)
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown (2018) (300)
The Hepatitis C Viruses (2000) (298)
Hepatitis C Virus RNA Functionally Sequesters miR-122 (2015) (297)
A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. (2011) (293)
Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. (1989) (288)
Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes (2004) (286)
Genetic Interaction of Flavivirus Nonstructural Proteins NS1 and NS4A as a Determinant of Replicase Function (1999) (284)
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients (1996) (283)
Mutations in the Yellow Fever Virus Nonstructural Protein NS2A Selectively Block Production of Infectious Particles (2002) (283)
Characterization of a canine homolog of hepatitis C virus (2011) (276)
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components (2009) (275)
Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins. (1981) (275)
The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. (2001) (266)
Ultrastructural analysis of hepatitis C virus particles (2013) (265)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses (2020) (262)
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus (2015) (261)
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021) (257)
A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro (1995) (257)
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells (2008) (256)
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico (2017) (255)
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice (2013) (255)
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system (2010) (250)
Intrinsic Immunity Shapes Viral Resistance of Stem Cells (2017) (247)
Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological Properties (1999) (247)
Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase* (2001) (244)
Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. (1987) (241)
Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection (2013) (241)
miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity (2015) (240)
Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites (1991) (240)
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules (1995) (240)
A cis-Acting Replication Element in the Sequence Encoding the NS5B RNA-Dependent RNA Polymerase Is Required for Hepatitis C Virus RNA Replication (2004) (239)
Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses (2013) (236)
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice. (2011) (236)
Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. (1992) (235)
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage (2013) (235)
Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis (2008) (233)
Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics (1994) (230)
Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin (1996) (229)
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation (2015) (227)
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. (1998) (227)
Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism (2009) (227)
Alphavirus-based expression vectors: strategies and applications. (1996) (227)
Completion of the entire hepatitis C virus life-cycle in genetically humanized mice (2013) (224)
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host (2012) (223)
Humanized mice for modeling human infectious disease: challenges, progress, and outlook. (2009) (221)
Interaction between hepatitis C virus proteins and host cell factors. (2002) (221)
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease (2006) (221)
Roles of Nonstructural Protein nsP2 and Alpha/Beta Interferons in Determining the Outcome of Sindbis Virus Infection (2002) (221)
A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. (2003) (216)
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems (2014) (215)
Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA (1997) (214)
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. (2004) (214)
Identification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A Protein (2007) (214)
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures (2010) (213)
Modeling hepatitis C virus infection using human induced pluripotent stem cells (2012) (209)
Characterization of truncated forms of hepatitis C virus glycoproteins. (1997) (208)
Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees (2003) (205)
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner (2004) (203)
Broadly neutralizing antibodies abrogate established hepatitis C virus infection (2014) (202)
Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. (1998) (202)
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells (2009) (202)
Sindbis virus proteins nsP1 and nsP2 contain homology to nonstructural proteins from several RNA plant viruses (1985) (198)
Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication (2003) (196)
Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase (1997) (194)
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. (2005) (192)
Selection of RNA Replicons Capable of Persistent Noncytopathic Replication in Mammalian Cells (1999) (191)
Tracking and Elucidating Alphavirus-Host Protein Interactions* (2006) (190)
Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge (2002) (189)
Hepatitis C virus induces interferon‐λ and interferon‐stimulated genes in primary liver cultures (2011) (187)
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication (2004) (185)
Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. (2006) (185)
Diverse CD81 Proteins Support Hepatitis C Virus Infection (2006) (182)
Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks (2020) (180)
Identification of Interferon-Stimulated Genes with Antiretroviral Activity (2016) (180)
Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication (1993) (175)
Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site (1993) (174)
Structure of the Flavivirus Genome (1986) (171)
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks (2020) (171)
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants (2009) (169)
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. (2006) (169)
Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. (2011) (168)
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin. (2016) (168)
Bovine viral diarrhea virus NS3 serine proteinase: polyprotein cleavage sites, cofactor requirements, and molecular model of an enzyme essential for pestivirus replication (1997) (166)
Infectious Bovine Viral Diarrhea Virus (Strain NADL) RNA from Stable cDNA Clones: a Cellular Insert Determines NS3 Production and Viral Cytopathogenicity (1998) (165)
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro (2012) (164)
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees (2004) (164)
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins (1998) (163)
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein (2007) (162)
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. (2008) (161)
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans (2013) (161)
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. (2004) (161)
Partial nucleotide sequence of the Murray Valley encephalitis virus genome. Comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. (1986) (160)
The NS5A/NS5 Proteins of Viruses from Three Genera of the Family Flaviviridae Are Phosphorylated by Associated Serine/Threonine Kinases (1998) (160)
Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. (1996) (158)
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1) (2013) (157)
Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus (1999) (155)
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. (2012) (155)
Cis-acting RNA elements at the 5' end of Sindbis virus genome RNA regulate minus- and plus-strand RNA synthesis. (2001) (153)
Mapping of RNA- temperature-sensitive mutants of Sindbis virus: complementation group F mutants have lesions in nsP4 (1989) (153)
Oxidized low‐density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells (2006) (153)
Studying Hepatitis C Virus: Making the Best of a Bad Virus (2007) (152)
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells (2013) (151)
Evidence for a functional RNA element in the hepatitis C virus core gene (2007) (151)
New therapeutic strategies for hepatitis C (2002) (150)
IFITM3 directly engages and shuttles incoming virus particles to lysosomes (2019) (150)
euHCVdb: the European hepatitis C virus database (2006) (149)
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals (2020) (148)
Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response (2012) (147)
NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies (1994) (147)
A Dynamic View of Hepatitis C Virus Replication Complexes (2008) (146)
Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. (2014) (146)
Association of the Sindbis virus RNA methyltransferase activity with the nonstructural protein nsP1. (1989) (145)
Superinfection Exclusion in Cells Infected with Hepatitis C Virus (2007) (144)
Molecular biology of flaviviruses. (2003) (143)
Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. (2005) (141)
A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo (2012) (139)
Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection (2013) (138)
Sequence coding for the alphavirus nonstructural proteins is interrupted by an opal termination codon. (1983) (138)
TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP) (2017) (137)
Development and Application of a Reverse Genetics System for Japanese Encephalitis Virus (2003) (135)
Roles of nonstructural polyproteins and cleavage products in regulating Sindbis virus RNA replication and transcription (1993) (134)
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells (2012) (133)
Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera. (1990) (132)
Specificity of the hepatitis C virus NS3 serine protease: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing (1994) (132)
Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants (1985) (131)
Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. (1992) (131)
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes (2005) (131)
Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation (1997) (130)
Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. (2006) (130)
Genetic analysis of the nsP3 region of Sindbis virus: evidence for roles in minus-strand and subgenomic RNA synthesis (1994) (130)
3′ RNA Elements in Hepatitis C Virus Replication: Kissing Partners and Long Poly(U) (2007) (130)
The C Terminus of Hepatitis C Virus NS4A Encodes an Electrostatic Switch That Regulates NS5A Hyperphosphorylation and Viral Replication (2007) (129)
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes (2009) (127)
Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production. (2005) (126)
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients (2007) (125)
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation (2015) (125)
PKR-Dependent and -Independent Mechanisms Are Involved in Translational Shutoff during Sindbis Virus Infection (2004) (123)
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus (2007) (123)
Association of sindbis virion glycoproteins and their precursors. (1982) (121)
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease (2017) (121)
West Nile virus envelope proteins: nucleotide sequence analysis of strains differing in mouse neuroinvasiveness. (1998) (121)
Mutagenesis of the in-frame opal termination codon preceding nsP4 of Sindbis virus: studies of translational readthrough and its effect on virus replication (1989) (120)
The signal for translational readthrough of a UGA codon in Sindbis virus RNA involves a single cytidine residue immediately downstream of the termination codon (1993) (117)
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. (2018) (117)
Ross River virus 26 s RNA: complete nucleotide sequence and deduced sequence of the encoded structural proteins. (1983) (116)
SEC14L2 enables pan-genotype HCV replication in cell culture (2015) (113)
Host Factors Associated with the Sindbis Virus RNA-Dependent RNA Polymerase: Role for G3BP1 and G3BP2 in Virus Replication (2010) (113)
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens (2015) (113)
Phosphorylation of Sindbis virus nsP3 in vivo and in vitro. (1990) (111)
Dual Mechanisms of Pestiviral Superinfection Exclusion at Entry and RNA Replication (2005) (111)
Mechanism of action of a pestivirus antiviral compound. (2000) (111)
Mutations which alter the level or structure of nsP4 can affect the efficiency of Sindbis virus replication in a host-dependent manner (1990) (111)
Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis. (1989) (109)
Characterization of Infectious Retroviral Pseudotype Particles Bearing Hepatitis C Virus Glycoproteins (2004) (109)
Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins (2002) (107)
A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration. (2016) (106)
Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells (2006) (106)
Mutagenesis of the NS2B-NS3-Mediated Cleavage Site in the Flavivirus Capsid Protein Demonstrates a Requirement for Coordinated Processing (1999) (104)
Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness. (2014) (104)
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity (2009) (104)
A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape (2019) (104)
Sequence studies of several alphavirus genomic RNAs in the region containing the start of the subgenomic RNA. (1982) (103)
Partial nucleotide sequence of St. Louis encephalitis virus RNA: structural proteins, NS1, ns2a, and ns2b. (1987) (103)
Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage (1995) (102)
Isolation and Characterization of Noncytopathic Pestivirus Mutants Reveals a Role for Nonstructural Protein NS4B in Viral Cytopathogenicity (2001) (102)
Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines (2019) (101)
Emerging therapies for the treatment of hepatitis C (2013) (101)
The efficient intracellular sequestration of the insulin-regulatable glucose transporter (GLUT-4) is conferred by the NH2 terminus (1992) (100)
Assembly of functional Sindbis virus RNA replication complexes: requirement for coexpression of P123 and P34 (1993) (96)
Uncleaved NS2-3 Is Required for Production of Infectious Bovine Viral Diarrhea Virus (2004) (96)
Mouse models of acute and chronic hepacivirus infection (2017) (96)
The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. (1995) (96)
Template-Dependent Initiation of Sindbis Virus RNA Replication In Vitro (1998) (94)
Deletion and duplication mutations in the C-terminal nonconserved region of Sindbis virus nsP3: effects on phosphorylation and on virus replication in vertebrate and invertebrate cells. (1994) (92)
LY6E impairs coronavirus fusion and confers immune control of viral disease (2020) (91)
Genome sequences of a mouse-avirulent and a mouse-virulent strain of Ross River virus. (1988) (89)
Multiple tachykinins are produced and secreted upon post-translational processing of the three substance P precursor proteins, alpha-, beta-, and gamma-preprotachykinin. Expression of the preprotachykinins in AtT-20 cells infected with vaccinia virus recombinants. (1989) (89)
Hepatitis C Virus RNA Synthesis in a Cell-Free System Isolated from Replicon-Containing Hepatoma Cells (2003) (88)
Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness (2008) (88)
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies. (2007) (88)
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine (2021) (87)
CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope (1992) (87)
Molecular characterization of hepatitis C virus. (1998) (87)
Expression of Paramyxovirus V Proteins Promotes Replication and Spread of Hepatitis C Virus in Cultures of Primary Human Fetal Liver Cells (2011) (86)
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid. (2016) (86)
Towards a small animal model for hepatitis C (2009) (85)
Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. (1995) (84)
LY6E impairs coronavirus fusion and confers immune control of viral disease (2020) (84)
Mutagenesis of the yellow fever virus NS2A/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein. (1994) (84)
Identification and transcriptome analysis of erythroblastic island macrophages. (2019) (82)
cis-acting RNA elements required for replication of bovine viral diarrhea virus-hepatitis C virus 5' nontranslated region chimeras. (1998) (81)
Identification of the Major Phosphorylation Site of the Hepatitis C Virus H Strain NS5A Protein as Serine 2321* (1999) (81)
Identification of a Pegivirus (GB Virus-Like Virus) That Infects Horses (2013) (81)
Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist (2014) (81)
Expression of Sindbis virus structural proteins via recombinant vaccinia virus: synthesis, processing, and incorporation into mature Sindbis virions (1985) (80)
Characterization of nonprimate hepacivirus and construction of a functional molecular clone (2015) (80)
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy (2021) (79)
New insights into HCV replication: potential antiviral targets. (2011) (79)
Mutagenesis of the Signal Sequence of Yellow Fever Virus prM Protein: Enhancement of Signalase Cleavage In Vitro Is Lethal for Virus Production (2000) (79)
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors (2020) (79)
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission (2013) (79)
Engineering a Therapeutic Lectin by Uncoupling Mitogenicity from Antiviral Activity (2015) (78)
Functional cDNA clones of the Flaviviridae: strategies and applications. (1999) (77)
Nonstructural proteins nsP3 and nsP4 of Ross River and O'Nyong-nyong viruses: sequence and comparison with those of other alphaviruses. (1988) (77)
To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes (2015) (76)
Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication (2016) (75)
Transcriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core Protein (2001) (74)
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage of Mycobacterium tuberculosis Heat Shock Protein 70 Gene to an Antigen Gene1 (2001) (74)
Requirements at the 3′ End of the Sindbis Virus Genome for Efficient Synthesis of Minus-Strand RNA (2005) (74)
Temperature sensitive shut-off of alphavirus minus strand RNA synthesis maps to a nonstructural protein, nsP4. (1990) (73)
TMEM41B Is a Pan-flavivirus Host Factor (2020) (73)
Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C Virus (2004) (72)
Hepatitis C Virus Entry* (2008) (72)
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle (2010) (71)
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype (2013) (70)
ATP-dependent effector-like functions of RIG-I-like receptors. (2015) (70)
Molecular analysis of Sindbis virus pathogenesis in neonatal mice by using virus recombinants constructed in vitro (1988) (70)
Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C. (2011) (70)
Sindbis virus attachment: isolation and characterization of mutants with impaired binding to vertebrate cells (1993) (69)
Interfering with hepatitis C virus RNA replication. (2004) (69)
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients 1 (2003) (68)
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors (2020) (67)
Hepatitis C Virus Co-Opts Ras-GTPase-Activating Protein-Binding Protein 1 for Its Genome Replication (2011) (67)
Selection of Functional 5′ cis-Acting Elements Promoting Efficient Sindbis Virus Genome Replication (2004) (67)
Turning hepatitis C into a real virus. (2011) (67)
The IFN‐&lgr;‐IFN‐&lgr;R1‐IL‐10R&bgr; Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity (2017) (67)
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs (2021) (66)
Determinants of the Hepatitis C Virus Nonstructural Protein 2 Protease Domain Required for Production of Infectious Virus (2009) (66)
Identification and Characterization of the Host Protein DNAJC14 as a Broadly Active Flavivirus Replication Modulator (2011) (66)
Isolation and characterization of the hydrophobic COOH-terminal domains of the sindbis virion glycoproteins. (1982) (65)
New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product (2018) (64)
Multiple Interferon Stimulated Genes Synergize with the Zinc Finger Antiviral Protein to Mediate Anti-Alphavirus Activity (2012) (63)
Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice (2013) (63)
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA. (2017) (63)
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus (2014) (63)
Infectious enveloped RNA virus antigenic chimeras. (1992) (63)
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells. (2016) (62)
A cis-acting mutation in the Sindbis virus junction region which affects subgenomic RNA synthesis (1989) (61)
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir (2016) (61)
A research agenda for curing chronic hepatitis B virus infection (2018) (61)
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer. (2017) (61)
Inhibition of HIV-1 particle assembly by 2',3'-cyclic-nucleotide 3'-phosphodiesterase. (2012) (61)
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis (2016) (61)
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model (2018) (60)
Male germ cells support long-term propagation of Zika virus (2018) (59)
Partial N-terminal amino acid sequences of three nonstructural proteins of two flaviviruses. (1986) (59)
Characterization of Novel Splice Variants of Zinc Finger Antiviral Protein (ZAP) (2019) (58)
Mutagenesis of the yellow fever virus NS2B/3 cleavage site: determinants of cleavage site specificity and effects on polyprotein processing and viral replication (1995) (57)
Yellow fever 17D as a vaccine vector for microbial CTL epitopes (2005) (57)
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation (2007) (56)
Role of SR-BI in HCV entry: kinetics and molecular 1 determinants 2 (2009) (55)
Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains. (1992) (55)
Inherited IL-18BP deficiency in human fulminant viral hepatitis (2019) (55)
New horizons for studying human hepatotropic infections. (2010) (55)
A robust cell culture system supporting the complete life cycle of hepatitis B virus (2017) (53)
Hepatitis C Virus Core Protein Associates with Detergent-Resistant Membranes Distinct from Classical Plasma Membrane Rafts (2004) (53)
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing (2013) (53)
Bad time for Bonzo? Experimental models of hepatitis C virus infection, replication, and pathogenesis (2001) (53)
Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets. (1998) (53)
TMEM41B is a pan-flavivirus host factor (2020) (53)
Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain. (1996) (53)
A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates. (2018) (52)
AAV-Mediated Gene Therapy for Research and Therapeutic Purposes (2014) (52)
Biochemical studies of the maturation of the small Sindbis virus glycoprotein E3. (1984) (51)
Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry (2015) (51)
Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread. (2017) (51)
In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation. (1999) (51)
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (2018) (51)
The Frequency of CD127+ Hepatitis C Virus (HCV)-Specific T Cells but Not the Expression of Exhaustion Markers Predicts the Outcome of Acute HCV Infection (2013) (50)
Successful anti‐scavenger receptor class B type I (SR‐BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR‐BI‐targeting agents (2014) (50)
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins (2022) (50)
Innate immune responses to hepatitis C virus. (2013) (50)
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines. (2013) (49)
Structures of hepatitis C virus nonstructural proteins required for replicase assembly and function. (2013) (49)
Genetic Interactions between Hepatitis C Virus Replicons (2004) (48)
Stem cell-derived polarized hepatocytes (2020) (48)
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture (2016) (48)
The NS5A Protein of Bovine Viral Diarrhea Virus Contains an Essential Zinc-Binding Site Similar to That of the Hepatitis C Virus NS5A Protein (2006) (47)
The expression of chloramphenicol acetyltransferase in Aedes albopictus (C6/36) cells and Aedes triseriatus mosquitoes using a double subgenomic recombinant Sindbis virus. (1994) (47)
Genetic determinants of Sindbis virus neuroinvasiveness (1997) (46)
Flavivirus Replication Complex Assembly Revealed by DNAJC14 Functional Mapping (2012) (46)
Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms (2009) (45)
Long-Term Persistence of Infection in Chimpanzees Inoculated with an Infectious Hepatitis C Virus Clone Is Associated with a Decrease in the Viral Amino Acid Substitution Rate and Low Levels of Heterogeneity (2004) (45)
Bovine Viral Diarrhea Virus Core Is an Intrinsically Disordered Protein That Binds RNA (2007) (44)
Sequence analysis of cDNA's derived from the RNA of Sindbis virions and of defective interfering particles (1982) (44)
Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia. (2013) (44)
Synthesis, cleavage and sequence analysis of DNA complementary to the 26 S messenger RNA of Sindbis virus. (1981) (44)
CRISPR / Cas 9 cleavage of viral DNA efficiently suppresses hepatitis B virus (2015) (44)
Mutagenesis of conserved residues at the yellow fever virus 3/4A and 4B/5 dibasic cleavage sites: effects on cleavage efficiency and polyprotein processing. (1993) (43)
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster (2012) (43)
A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations. (2020) (42)
Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein (2009) (42)
Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1. (2012) (41)
Efficient Translation Initiation Is Required for Replication of Bovine Viral Diarrhea Virus Subgenomic Replicons (2001) (41)
Splicing Diversity of the Human OCLN Gene and Its Biological Significance for Hepatitis C Virus Entry (2010) (41)
Risk of Zika microcephaly correlates with features of maternal antibodies (2019) (40)
Hepatitis C: Treatment triumphs (2014) (40)
Hepatitis C virus-specific T lymphocyte responses. (1995) (40)
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors (2015) (40)
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. (2007) (39)
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies (2022) (37)
New therapies on the horizon for hepatitis C: are we close? (2003) (37)
Functionally distinct T-cell epitopes within the hepatitis C virus non-structural 3 protein. (1999) (37)
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus (2016) (37)
Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems. (2017) (36)
Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies (2002) (36)
RNAi targeting an animal virus: news from the front. (2002) (36)
ZAP’s stress granule localization is correlated with its antiviral activity and induced by virus replication (2019) (35)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals (2020) (35)
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus (2015) (35)
Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro (2020) (35)
C7L Family of Poxvirus Host Range Genes Inhibits Antiviral Activities Induced by Type I Interferons and Interferon Regulatory Factor 1 (2012) (35)
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment (2017) (34)
Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein. (2001) (34)
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20 (2018) (34)
Expansion, in vivo–ex vivo cycling, and genetic manipulation of primary human hepatocytes (2020) (34)
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development. (2010) (33)
Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-Acting Antiviral Agents (2014) (32)
Identification of a Dominant Negative Inhibitor of Human Zinc Finger Antiviral Protein Reveals a Functional Endogenous Pool and Critical Homotypic Interactions (2010) (30)
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance (2018) (29)
Hepatitis B virus induces RNR-R2 expression via DNA damage response activation. (2015) (29)
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia (2022) (29)
Sindbis virus ts103 has a mutation in glycoprotein E2 that leads to defective assembly of virions (1989) (28)
Rubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes (1993) (28)
miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence (2017) (28)
Replication and single-cycle delivery of SARS-CoV-2 replicons (2021) (28)
Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C (2005) (27)
The IFN-lambda-IFN-lambda R1-IL-10R beta Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity. (2017) (26)
Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii. (2010) (26)
Defining the proteolytic landscape during enterovirus infection (2020) (26)
Proteasome activator and antigen-processing aminopeptidases are regulated by virus-induced type I interferon in the hepatitis C virus-infected liver. (2007) (26)
Differential Regulation of Lipoprotein and Hepatitis C Virus Secretion by Rab1b. (2017) (26)
A Single Nucleotide Change in the 5′ Noncoding Region of Sindbis Virus Confers Neurovirulence in Rats (1999) (26)
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice (2015) (24)
Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection (2010) (24)
Insufficient interleukin‐12 signalling favours differentiation of human CD4+ and CD8+ T cells into GATA‐3+ and GATA‐3+ T‐bet+ subsets in humanized mice (2014) (23)
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop (2017) (23)
Study of hepatitis C virus entry in genetically humanized mice. (2013) (23)
FLA \lIVIRUS GENOME ORGJ\NIZATION, EXPRESSION, AND REPLICATION (1990) (23)
Hepatitis C virus cell culture replication systems: their potential use for the development of antiviral therapies (2001) (23)
Chaperone-Assisted Protein Folding Is Critical for Yellow Fever Virus NS3/4A Cleavage and Replication (2016) (22)
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B (2014) (22)
Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms (2021) (22)
Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein. (2013) (21)
Is CD81 the key to hepatitis C virus entry? (1999) (21)
Genetic and Functional Characterization of the N-Terminal Region of the Hepatitis C Virus NS2 Protein (2013) (21)
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4 (2015) (20)
Seed Sequence-Matched Controls Reveal Limitations of Small Interfering RNA Knockdown in Functional and Structural Studies of Hepatitis C Virus NS5A-MOBKL1B Interaction (2014) (20)
Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach (2015) (19)
Perspective: Miles to go before we sleep (2011) (19)
Molecular Cloning of Flavivirus Genomes for Comparative Analysis and Expression (1988) (19)
Transdominant Inhibition of Bovine Viral Diarrhea Virus Entry (2007) (19)
Identification of interferon-stimulated genes that attenuate Ebola virus infection (2020) (19)
New Methods in Tissue Engineering: Improved Models for Viral Infection. (2014) (19)
Sindbis virus mutant ts20 of complementation group E contains a lesion in glycoprotein E2. (1986) (19)
Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA. (2017) (19)
RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology (2020) (19)
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient Derived Xenografts and Direct from Patient Screening. (2021) (18)
Antiviral resistance of stem cells. (2019) (18)
Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients (2018) (18)
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons. (2017) (18)
Development of a multiplex phenotypic cell-based high throughput screening assay to identify novel hepatitis C virus antivirals. (2013) (18)
The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production (2015) (17)
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies (2022) (17)
Global mapping of miRNA-target interactions in cattle (Bos taurus) (2017) (17)
Overview of flavivirus molecular biology and future vaccine development via recombinant DNA. (1990) (17)
SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs (2020) (17)
A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques (2020) (16)
NS5A Promotes Constitutive Degradation of IP3R3 to Counteract Apoptosis Induced by Hepatitis C Virus. (2018) (16)
Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins (2022) (16)
Liver-expressed Cd302 and Cr1l limit hepatitis C virus cross-species transmission to mice (2020) (15)
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies. (2016) (15)
Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis (2020) (15)
System-wide transcriptome damage and tissue identity loss in COVID-19 patients (2022) (15)
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality (2020) (15)
Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance (2016) (15)
Antisense Gets a Grip on miR-122 in Chimpanzees (2010) (15)
Stem Cell-Derived Culture Models of Hepatitis E Virus Infection. (2019) (14)
Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year. (2021) (14)
The N-terminus of PE2 in Sindbis virus-infected cells. (1982) (14)
Predicting response to hepatitis C therapy. (2008) (14)
Single‐molecule imaging reveals the translocation and DNA looping dynamics of hepatitis C virus NS3 helicase (2017) (14)
Getting Rid of a Persistent Troublemaker to Cure Hepatitis (2014) (14)
Treating hepatitis C: Can you teach old dogs new tricks? (2005) (14)
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication (2018) (14)
Expanding the Host Range of Hepatitis C Virus through Viral Adaptation (2016) (14)
RNA viruses as gene expression vectors (1989) (13)
Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease (2021) (12)
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action* (2016) (12)
Examples of expression systems based on animal RNA viruses: Alphaviruses and influenza virus (1992) (12)
Rescue of Sindbis virus-specific RNA replication and transcription by using a vaccinia virus recombinant (1991) (12)
The role of host immunocompetence in neuroinvasion of Sindbis virus (1999) (12)
Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children (2022) (12)
Diverse CD 81 Proteins Support Hepatitis C Virus Infection (2006) (12)
Alphavirus-based expression systems. (1996) (11)
Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity (2015) (11)
Evasive maneuvers by hepatitits C virus (2003) (11)
A big role for small RNAs in influenza virus replication (2010) (11)
Hepatitis C: An unsuspected drug target (2010) (11)
Class I MHC molecule-mediated inhibition of Sindbis virus replication. (1999) (11)
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion (2016) (10)
Visualization of Positive and Negative Sense Viral RNA for Probing the Mechanism of Direct-Acting Antivirals against Hepatitis C Virus (2019) (10)
Mopping up miRNA: An integrated HBV transcript disrupts liver homeostasis by sequestering miR-122. (2016) (10)
Friend and foe, HNRNPC takes on immunostimulatory RNAs in breast cancer cells (2018) (10)
Pathogenesis, MicroRNA‐122 Gene‐Regulation, and Protective Immune Responses After Acute Equine Hepacivirus Infection (2021) (10)
Creation and characterization of a cell-death reporter cell line for hepatitis C virus infection. (2010) (10)
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells (2019) (10)
Generation of a reporter yellow fever virus for high throughput antiviral assays (2020) (9)
Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals (2021) (9)
Immunization with nonstructural proteins promotes functional recovery of alphavirus-infected neurons (1997) (9)
Taming a beast: lessons from the domestication of hepatitis C virus. (2019) (9)
Hepatitis C Virus Polyprotein Processing (1994) (9)
Green fluorescent protein‐tagged apolipoprotein E: A useful marker for the study of hepatic lipoprotein egress (2017) (9)
Uncleaved NS 2-3 Is Required for Production of Infectious Bovine Viral Diarrhea Virus (2004) (9)
Review article: HCV ? STAT-C era of therapy (2010) (8)
The Molecular Biology of Hepatitis C Virus (2002) (8)
Investigating the functional link between TMEM165 and SPCA1. (2019) (8)
Use of enzyme immunoassay and nucleic acid hybridization for detecting Sindbis virus in infected mosquitoes. (1987) (8)
Evasive maneuvers by hepatitis C virus. (2003) (8)
IL6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease. (2022) (8)
Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice (2017) (8)
Common human genetic variants of APOE impact murine COVID-19 mortality (2022) (8)
Quantitative measurements of early alphaviral replication dynamics in single cells reveals the basis for superinfection exclusion. (2021) (8)
A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape (2019) (7)
Human IFIT3 Protein Induces Interferon Signaling and Inhibits Adenovirus Immediate Early Gene Expression (2021) (7)
Locking out hepatitis C (2011) (7)
Single cell analysis of HCV-infected patient hepatocytes: the science is no longer science fiction. (2013) (7)
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes (2020) (7)
Sequence of the 3′ half of the Murray Valley encephalitis virus genome and mapping of the nonstructural proteins NS1, NS3, and NS5 (1990) (7)
Expression of the structural proteins of dengue 2 virus and yellow fever virus by recombinant vaccinia viruses (2005) (6)
A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines (2020) (6)
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody (2020) (6)
Virology: Fresh assault on hepatitis C (2003) (6)
Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice. (2011) (6)
Submission of nucleotide sequence data to EMBL/GenBank/DDBJ. (1996) (6)
Detection of yellow fever virus nucleic acid in infected mosquitoes by RNA:RNA in situ hybridization. (1988) (6)
T time for ADAR: ADAR1 is required for T cell self‐tolerance (2018) (6)
Present and not reporting for duty: dsRNAi in mammalian cells (2016) (6)
At Federation Square (2004) (6)
IFN b -dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage (2013) (5)
Superinfection exclusion of BVDV occurs not only at the level of structural protein-dispensable viral replication but also at the level of structural protein-required viral entry (2000) (5)
Expression and Characterization of the HCV NS2 Protease. (1999) (5)
Examples of expression systems based on animal RNA viruses: Alphaviruses and influenza virus (1992) (5)
In memoriam--Richard M. Elliott (1954-2015). (2015) (5)
Chapter 8 – Replication and Pathogenesis of Hepatitis C Virus (2006) (4)
DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2 (2021) (4)
Su1581 Modeling Hepatitis C Virus Infection Using Human Induced Pluripotent Stem Cells (2012) (4)
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria (2023) (4)
A histone-like motif in yellow fever virus contributes to viral replication (2020) (4)
Argonaute-CLIP delineates versatile, functional RNAi networks in Aedes aegypti, a major vector of human viruses. (2021) (4)
Cell lines that allow regulated expression of HCV proteins: principles and applications (2003) (4)
Cloning and assembly of complex libraries of full-length HCV cDNA clones. (1999) (4)
Single-Molecule Imaging Reveals the Translocation Dynamics of Hepatitis C Virus NS3 Helicase (2014) (3)
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma (2022) (3)
Bringing the Hepatitis C Virus to Life (2016) (3)
1401 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES VARIANTS ASSOCIATED WITH LIVER FIBROSIS PROGRESSION IN HCV-INFECTED PATIENTS (2012) (3)
An RNA-based system to study hepatitis B virus replication and select drug-resistance mutations (2019) (3)
A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry (2021) (3)
in patients with hepatitis C Plasma chemokine levels correlate with the outcome of antiviral therapy (2013) (3)
Repurposing an old drug: A low‐cost allergy medication provides new hope for hepatitis C patients (2015) (3)
Lung type II alveolar epithelial cells collaborate with CCR2+ inflammatory monocytes in host defense against an acute vaccinia infection in the lungs (2020) (3)
Keeping Track of Viruses (2005) (3)
Hepatitis C Virus-From Discovery to Cure: The 2016 Lasker-DeBakey Clinical Medical Research Award. (2016) (3)
Amphibian, Fish, and Bird Immunotoxicology (2006) (3)
Molecular modelling predicts SARS-CoV-2 ORF8 protein and human complement Factor 1 catalytic domain sharing common binding site on complement C3b (2020) (3)
Inaugural Article: Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism (2010) (3)
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice. (2021) (2)
Host factors associated with the Sindbis virus RNA-dependent RNA polymerase : 1 a role for G 3 BP 1 and G 3 BP 2 in virus replication 2 3 (2010) (2)
End game: Getting the most out of microRNAs (2011) (2)
Natural History, Pathogenesis, and Prevention of HCV Infection (2012) (2)
Use of the vaccinia virus/t7 expression system for studying HCV protein processing. (1999) (2)
Proteomic elucidation of the targets and primary functions of the picornavirus 2A protease (2022) (2)
Downregulation of IGF2 expression in third trimester placental tissues from Zika virus infected women in Brazil. (2020) (2)
Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120. (2017) (2)
Sindbis Macrodomain Poly-ADP-Ribose Hydrolase Activity Is Important for Viral RNA Synthesis (2022) (2)
Cycluridine: A novel antiviral effective against flaviviruses (2017) (2)
A human iPSC-array-based GWAS identifies a virus susceptibility locus in the NDUFA4 gene and functional variants (2022) (2)
Human FcγRIIIa activation on splenic macrophages drives the in vivo pathogenesis of dengue disease (2022) (2)
Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus (2020) (2)
Neutralization and receptor use of infectious culture–derived rat hepacivirus as a model for HCV (2022) (2)
Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. (2011) (2)
Identification of claudin-1 as an essential cellular cell entry factor for hepatitis C virus (2006) (2)
Author Correction: A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines (2021) (2)
Freeze Drying Method with Gaseous Nitrogen to Preserve Fine Ultrastructure of Biological Organizations for Scanning Electron Microscopy, Helium Ion Beam Microscopy and Fluorescence Microscopy (2016) (2)
Hepatitis C virus replicons finally get to second base. (2003) (2)
HEPATITIS Oxidized Low-Density Lipoprotein Inhibits Hepatitis C Virus Cell Entry in Human Hepatoma Cells (2006) (2)
Resource Identification of Interferon-Stimulated Genes with Antiretroviral Activity Graphical (2016) (1)
Human anti-ACE2 monoclonal antibodies as pan-sarbecovirus prophylactic agents (2022) (1)
Intratumoral delivery of engineered recombinant modified vaccinia virus Ankara expressing Flt3L and OX40L generates potent antitumor immunity through activating the cGAS/STING pathway and depleting tumor-infiltrating regulatory T cells (2021) (1)
401 Hepatitis C virus has a cis-acting replication element in the polymerase gene: a new feature of the HCV genome with implications for drug development (2003) (1)
Hepatitis C Patients Naive , Resting Phenotype in a Subset of Accumulation of B Lymphocytes with a Rice (2003) (1)
Frontiers in Drug Development for Viral Hepatitis The 6th biennial meeting in this HEP DART series (2005) (1)
Cell-impermeable staurosporine analog targets extracellular kinases to inhibit HSV and SARS-CoV-2 (2022) (1)
Erratum: Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture (2017) (1)
Public broadly neutralizing antibodies against hepatitis B virus in individuals with elite serologic activity (2020) (1)
Aiphavirus-based expression vectors: Strategies and applications (2005) (1)
Structure of the zinc-binding domain of HCV NS5A (2005) (1)
The hepatitis C viruses: Preface (2000) (1)
30 years ago in Clinical Toxicology. (1998) (1)
HCV and Blood Cells: How Can We Distinguish Infection from Association? (2012) (1)
Human hepatocyte PNPLA3 148M exacerbates rapid non-alcoholic steatohepatitis development in chimeric mice (2020) (1)
HCV Molecular Virology and Animal Models (2019) (1)
MappingofRNA- Temperature-Sensitive Mutants ofSindbis Virus: Complementation GroupFMutants HaveLesions innsP4 (1989) (1)
Host genetic variation guides hepacivirus clearance, chronicity, and liver fibrosis in mice (2023) (1)
Characterization of Live-Attenuated Powassan Virus Vaccine Candidates Identifies an Efficacious Prime-Boost Strategy for Mitigating Powassan Virus Disease in a Murine Model (2023) (1)
Spatial omics technologies at multimodal and single cell/subcellular level (2022) (1)
Self-organized stem cell-derived human lung buds with proximo-distal patterning and novel targets of SARS-CoV-2 (2021) (0)
Stem cell-derived polarized hepatocytes (2020) (0)
Hepatitis C Virus (HCV) (2002) (0)
Organotypic human lung bud microarrays identify BMP-dependent SARS-CoV-2 infection in lung cells (2023) (0)
Teaching New Tricks to an Old Foe: Murinizing Hepatitis C Virus (2010) (0)
Probing Helicase Dynamics on Nucleic Acids through Fluorescence-Force Measurements (2016) (0)
Male germ cells support long-term propagation of Zika virus (2018) (0)
MINIREVIEW Studying Hepatitis C Virus: Making the Best of a Bad Virus (cid:1) (2007) (0)
Construction of recombinant sindbis-based expression vectors for the study of HCV genes and their products. (1999) (0)
Chair's Introduction (2008) (0)
Antiviral Agents Replicons for Evaluation of Direct-Acting Hepatitis C Virus Genotype 5 a Subgenomic (2014) (0)
Keeping Track of Viruses (2010) (0)
Biographical Feature: Marc S. Collett (23 May 1951–11 June 2022): the Battle against Viral Disease Has Lost a Valiant Warrior, and the World Has Lost a Splendid Human Being (2022) (0)
A robust cell culture system supporting the complete life cycle of hepatitis B virus (2017) (0)
Differential Regulation of L ipoprotein andHepatitis C Virus Secretion by Rab 1 b Graphical Abstract Highlights (2017) (0)
PS1-122 Unraveling the complexity of the type I interferon antiviral response (2011) (0)
Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus (2023) (0)
News and Views December 2020 (2020) (0)
Shock Protein 70 Gene to an Antigen Gene Heat Mycobacterium tuberculosis Linkage of Self-Replicating RNA Vaccine Potency by Enhancement of Sindbis Virus (2001) (0)
Construction characterization and application of Flavivirus infectious clones (2013) (0)
A Freeze Drying Sample Preparation Method for Correlative Light and Scanning/Transmission Electron Microscopy (2017) (0)
A minimally-edited mouse model for infection with multiple SARS-CoV-2 strains (2022) (0)
Molecular Determinants of Mouse Adaptation of Rat Hepacivirus (2023) (0)
Innate immunity: trolling, responding and protecting against viral infections. (2011) (0)
An RNA-based system to study hepatitis B virus replication and evaluate antivirals (2023) (0)
Freeze Drying Method with Gaseous Nitrogen for Biological Application of Helium Ion Microcopy (2017) (0)
THE PERCENTAGE OF HEPATITIS C VIRUS-SPECIFIC CD127+MEMORY T CELLS IN THE ACUTE PHASE T CELL RESPONSE PREDICTS THE OUTCOME OF HCV INFECTION (2011) (0)
University of Birmingham Neutralizing antibody response during acute and chronic hepatits C virus infection (2004) (0)
Didox (3,4-Dihydroxybenzohydroxamic acid) is a potent anti-oxidant and anti-inflammatory compound (35.17) (2010) (0)
1146 THE EFFECTS OF BROADLY NEUTRALIZING ANTIBODIES IN EXPERIMENTAL HCV INFECTION (2013) (0)
739 Mathematical modeling of subgenomic hepatitis C viral replication in HUH-7 cells (2006) (0)
Voice Production with the Aid of Phonetics (2015) (0)
Museum of Ecological Succession (2007) (0)
The Antipodean relation (2002) (0)
Short English poems for repetition (2010) (0)
It Floats...Or Does It (1974) (0)
SAT-188-Expansion and genetic modification of primary hepatocytes to study long-term hepatitis B virus infection (2019) (0)
Antimicrobial Resistance: Agricultural Perspectives (2015) (0)
Seeing whiteness in colour (2001) (0)
Stalking John Portman (2012) (0)
How to draw in Dad (2009) (0)
Series : Host-pathogen interactions Emerging therapies for the treatment of hepatitis C (2013) (0)
infection Broadly neutralizing antibodies abrogate established hepatitis C virus (2014) (0)
381 Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes in living cells (2003) (0)
a Cohort of Persons with Chronic Infection in Infection: Breadth and Specificity of Responses Liver-Derived CTL in Hepatitis C Virus (1998) (0)
Infection of Tupaia belangeri by hepatitis C virus using an RNAtranscript (2000) (0)
Cross-genotype hepatitis C virus (HCV)-specific cytotoxic T lymphocyte (CTL) activity in the liver in chronic hepatitis C (1995) (0)
Fitness-Associated Mechanism of Drug Resistance in Hepatitis C Virus (2016) (0)
Identification of interferon-stimulated genes that attenuate Ebola virus infection (2020) (0)
Proteomics of HCV virions reveals an essential role for Nup98 in virus morphogenesis (2015) (0)
SAFETY AND EFFICACY OF VIRAMIDINE | PLUS PEGYLATED INTERFERON ALPHA-2B VERSUS RIBAVIRIN PLUS PEGYLATED INTERFERON ALPHA-2B IN THERAPY-NA'I'VE PATIENTS INFECTED WITH HCV: (2006) (0)
800 INHIBITION OF HEPATITIS C VIRUS REPLICATION BY RNA APTAMERS FOR IDENTIFYING SUITABLE THERAPEUTIC TARGETS (2011) (0)
Running Title: In vitro replication system for HCV genotypes 5a 2 (2014) (0)
Identiﬁcation of a Dominant Negative Inhibitor of Human Zinc Finger Antiviral Protein Reveals a Functional Endogenous Pool and Critical Homotypic Interactions (cid:1) (2010) (0)
Structure of the catalytic domain of hepatitis C virus NS2 (2006) (0)
Partial clearance of a hepatotropic virus infection in HLA class I and II double transgenic human immune system mice (105.19) (2012) (0)
MiceHLA-Transgenic Human Immune System Hepatotropic Virus Infection in Adaptive Immune Responses during Characterization of Human Antiviral (2013) (0)
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication (2018) (0)
Hepatitis C: Toward a Cure and Eradication (2012) (0)
Correlating Mobility and Interaction of Transcription Factors by SPIM-FCS (0)
An Animal Model for the Study of BBB Modulators (2001) (0)
with hepatitis C virus Presence of functional dendritic cells in patients chronically infected (2011) (0)
O112 GENERATION OF MICE WITH SYNGENEIC HUMAN LIVER AND IMMUNE SYSTEM TO STUDY CELLULAR IMMUNITY TO HEPATITIS B VIRUS (2014) (0)
HCV-associated mixed cryoglobulinemia B cells in + CD27 + Clonal expansion of immunoglobulin M (2011) (0)
Hepatocellular carcinoma patient derived xeno-engraftment is enhanced by murine liver injury (2016) (0)
Virus Replication Complexes Visualization of Functional Hepatitis C Nonstructural Protein 5A Allows Direct Insertion of Green Fluorescent Protein into (2014) (0)
the Outcome of Acute HCV Infection Expression of Exhaustion Markers Predicts (HCV)-Specific T Cells but Not the The Frequency of CD127+ Hepatitis C Virus (2013) (0)
Selection of Functional 5 (cid:2) cis -Acting Elements Promoting Efﬁcient Sindbis Virus Genome Replication (2003) (0)
Faculty Opinions recommendation of A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. (2017) (0)
Self-Organizing, Symmetry Breaking, Isogenic Human Lung Buds on Microchips Identify Alveolar Stem Cells as Novel Targets of SARS-CoV-2 (2021) (0)
P0545 : Targeting viral DNA with CRISPR/Cas9 robustly suppresses hepatitis B virus (2015) (0)
Sindbis VirusExpression Vectors: Packaging ofRNA Replicons byUsingDefective HelperRNAs (1993) (0)
Identification, Isolation and Transcriptome Analyses of Mouse, Rat and Man Erythroblastic Island Central Macrophages (2018) (0)
T Cell Response + CD8Broad and Polyfunctional Human Memory The Yellow Fever Virus Vaccine Induces a (2009) (0)
Single-Molecule Analysis of Hepatitis C Virus NS3 Helicase Translocating on Single-Stranded RNA (2014) (0)
the Outcome of Acute HCV Infection Expression of Exhaustion Markers Predicts (HCV)-Specific T Cells but Not the Hepatitis C Virus + The Frequency of CD127 (2014) (0)
Infectious, kimæriskt hepatitis C virus, to processes for their preparation and methods of use thereof (2006) (0)
Early alphavirus replication dynamics in single cells reveal a passive basis for superinfection exclusion (2020) (0)
Cleavage ata NovelSiteintheNS4ARegionbytheYellowFever VirusNS2B-3Proteinase Isa Prerequisite forProcessing attheDownstream 4A/4BSignalase Site (1993) (0)
Functional and structural studies of MOBKL1B, a Salvador/Warts/Hippo tumor suppressor pathway, in HCV replication (2014) (0)
Global mapping of miRNA-target interactions in cattle (Bos taurus) (2017) (0)
Diverse Hepaciviruses in a New Host Serology-Enabled Discovery of Genetically (2012) (0)
HIV-1 replication in CEM-GXR cells. (2015) (0)
Gene expression profiling of B cells in chronic hepatitis C (2007) (0)
Clonal expansion of immunoglobulin M (cid:1) CD27 (cid:1) B cells in HCV-associated mixed cryoglobulinemia (2008) (0)
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN- (cid:1) / (cid:2) on antigen cross-presentation (2007) (0)
Investigations into the receptor requirements of Hepatitis C Virus (HCV) pseudoparticles and cell culture grown virions (2006) (0)
University of Birmingham Superinfection Exclusion in Cells Infected with Hepatitis C Virus (2007) (0)
Expression ofSindbis VirusStructural Proteins viaRecombinant Vaccinia Virus: Synthesis, Processing, andIncorporation into MatureSindbis Virions (1985) (0)
Chapter 7 – Replication of Hepatitis C Virus (2012) (0)
Hepatitis C Virus Endopeptidase 2 (2013) (0)
18. THE MOLECULAR VIROLOGY OF HEPATITIS C VIRUS (2004) (0)
Mo1783 Personalizing the Study of Infectious Disease: Modeling Hepatitis C Virus Using Induced Pluripotent Stem Cells (2013) (0)
University of Birmingham Diverse CD81 Proteins Support Hepatitis C Virus Infection (2006) (0)
Assembly ofFunctional Sindbis VirusRNA Replication Complexes: Requirement forCoexpression ofP123andP34 (1993) (0)
Emerging New Issues in the Management of Hepatitis C Infection (2012) (0)
Correction: miRNA independent hepacivirus variants suggest a strong evolutionary pressure to maintain miR-122 dependence (2018) (0)
Drug Testing of Dengue Virus Infection and Antiviral Utility of Humanized BLT Mice for Analysis (2014) (0)
27 Hepatitis C Virus - Pathogenesis, Replication and Treatment (2012) (0)
RolesofNonstructural Polyproteins andCleavage Products in Regulating Sindbis VirusRNA Replication andTranscription (1993) (0)
New 3 'terminal sequence of hepatitis C viral genome and its diagnostic and therapeutic use (1996) (0)
Sindbis VirusAttachment: Isolation andCharacterization of Mutants withImpaired Binding toVertebrate Cells (1993) (0)
Studies on the Structural Proteins of Sindbis Virus (1981) (0)
101 HUMAN MONOCLONAL ANTIBODIES TARGETING SR-BI PREVENT HCV ENTRY AND VIRAL SPREAD IN VIVO (2011) (0)
103 RECAPITULATION OF THE ENTIRE HEPATITIS C VIRUS LIFE IN ENGINEERED MOUSE CELL LINES (2012) (0)
Identification of ADAR1 p150 and p110 Associated Edit Sites. (2023) (0)
Biographical Feature: James H. Strauss, Jr. (1938–2021) (2022) (0)
Didox (Dihydroxybenzohydroxamic acid) ameliorates macrophage AhR activation, CYP1A1/AhR Induction, and oxidative stress profiles induced by PCB-126 (35.16) (2010) (0)
OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs. (2023) (0)
Editorial (2019) (0)
Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United States (2021) (0)

This paper list is powered by the following services:

Other Resources About Charles M. Rice

What Schools Are Affiliated With Charles M. Rice?

Charles M. Rice is affiliated with the following schools:

Charles M. Rice's Academic­Influence.com Rankings